Product Code: ETC8834920 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The asthma disease market in the Philippines reflects the growing burden of respiratory conditions, particularly in polluted and densely populated areas. Public health initiatives, improved diagnostics, and better treatment options are central to addressing this challenge.
The asthma disease market is shaped by rising incidence, better diagnosis rates, and growing awareness of chronic respiratory conditions. Public health campaigns and school-based asthma management programs are helping improve early intervention and disease control.
The Asthma Disease Market in the Philippines faces challenges related to the increasing prevalence of asthma, particularly among children, in a country where air pollution, smoking, and inadequate healthcare infrastructure are common. There is also a lack of awareness about asthma management among the general population, which affects the early diagnosis and treatment of the disease. Public health campaigns to raise awareness and educate people about the disease and its treatment options are still underdeveloped. Additionally, the market struggles with affordability, as many asthma medications and treatment options are too expensive for lower-income families, leading to poor treatment adherence and outcomes.
The Philippines Asthma Disease Market is growing due to increased awareness, better diagnosis, and rising healthcare access. With the prevalence of asthma on the rise, there is a growing need for effective treatments and interventions. Investing in innovative asthma therapies, including biologics, corticosteroids, and bronchodilators, presents opportunities for companies in the pharmaceutical and medical device sectors. The growing number of asthma patients, combined with advancements in treatment options, offers significant growth potential in this market.
In the Philippines, the asthma disease market is regulated by the Department of Health (DOH), which works to ensure effective asthma management across the population. The government offers subsidies and health insurance programs for asthma treatments, making medications and treatments more accessible to individuals with asthma. In addition, public health initiatives raise awareness about the prevention and management of asthma, and healthcare providers are encouraged to adopt the latest treatment protocols. These efforts are designed to reduce asthma-related mortality and improve the quality of life for people with asthma in the Philippines.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Asthma Disease Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Asthma Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Asthma Disease Market - Industry Life Cycle |
3.4 Philippines Asthma Disease Market - Porter's Five Forces |
3.5 Philippines Asthma Disease Market Revenues & Volume Share, By Classification Type, 2021 & 2031F |
3.6 Philippines Asthma Disease Market Revenues & Volume Share, By Duration of Action Type, 2021 & 2031F |
3.7 Philippines Asthma Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Philippines Asthma Disease Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Philippines Asthma Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Asthma Disease Market Trends |
6 Philippines Asthma Disease Market, By Types |
6.1 Philippines Asthma Disease Market, By Classification Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Asthma Disease Market Revenues & Volume, By Classification Type, 2021- 2031F |
6.1.3 Philippines Asthma Disease Market Revenues & Volume, By Mild Intermittent Asthma, 2021- 2031F |
6.1.4 Philippines Asthma Disease Market Revenues & Volume, By Mild Persistent Asthma, 2021- 2031F |
6.1.5 Philippines Asthma Disease Market Revenues & Volume, By Moderate Persistent Asthma, 2021- 2031F |
6.1.6 Philippines Asthma Disease Market Revenues & Volume, By Severe Persistent Asthma, 2021- 2031F |
6.2 Philippines Asthma Disease Market, By Duration of Action Type |
6.2.1 Overview and Analysis |
6.2.2 Philippines Asthma Disease Market Revenues & Volume, By Long-Term Asthma Control Medications, 2021- 2031F |
6.2.3 Philippines Asthma Disease Market Revenues & Volume, By Inhaled Corticosteroids, 2021- 2031F |
6.2.4 Philippines Asthma Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.2.5 Philippines Asthma Disease Market Revenues & Volume, By Tiotropium Bromide, 2021- 2031F |
6.2.6 Philippines Asthma Disease Market Revenues & Volume, By Leukotriene Modifiers, 2021- 2031F |
6.2.7 Philippines Asthma Disease Market Revenues & Volume, By Long-Acting Beta Agonists, 2021- 2031F |
6.3 Philippines Asthma Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Philippines Asthma Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Philippines Asthma Disease Market Revenues & Volume, By Inhaled, 2021- 2031F |
6.3.4 Philippines Asthma Disease Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.5 Philippines Asthma Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Philippines Asthma Disease Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Philippines Asthma Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Philippines Asthma Disease Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Philippines Asthma Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Philippines Asthma Disease Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Asthma Disease Market Import-Export Trade Statistics |
7.1 Philippines Asthma Disease Market Export to Major Countries |
7.2 Philippines Asthma Disease Market Imports from Major Countries |
8 Philippines Asthma Disease Market Key Performance Indicators |
9 Philippines Asthma Disease Market - Opportunity Assessment |
9.1 Philippines Asthma Disease Market Opportunity Assessment, By Classification Type, 2021 & 2031F |
9.2 Philippines Asthma Disease Market Opportunity Assessment, By Duration of Action Type, 2021 & 2031F |
9.3 Philippines Asthma Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Philippines Asthma Disease Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Philippines Asthma Disease Market - Competitive Landscape |
10.1 Philippines Asthma Disease Market Revenue Share, By Companies, 2024 |
10.2 Philippines Asthma Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |